News Archive

13 March 2013

Merck Animal Health Highlights the Importance of Tilapia Health VIV Asia 2013

Attendees Gain Valuable Information on the benefits of vaccination programs 

BANGKOK, THAILAND, 13 March, 2013 – Merck Animal Health (known as Merck Animal Health in USA and Canada) recently hosted an educational symposium aimed at increasing the awareness of good fish health management to help sustainable and profitable growth in tilapia operations. Held prior to VIV Asia 2013, the session gave local tilapia farmers the opportunity to learn about the latest vaccination techniques from experts in the field.

Diseases, such as Streptococcus, have a significant impact on fish production in Asia and other tilapia-producing countries. The key to disrupting the disease cycle in fish farms is to start with a good understanding of key diseases impacting production. Finding a vaccination solution for farmers is a challenging process that requires extensive research and testing, both in the laboratory and field.

Attendees of the symposium learned about the life-cycle of vaccine development, appropriate and effective use of vaccines as part of the disease management protocol, and best practice from peers around the world.

“Asia accounts for 70% of all fish production in the world. It is important that fish farmers have a strong understanding of the best way to manage the health of their fish,” stated Robin Wardle, Global Strategic Marketing Director, Aquaculture. “Merck Animal Health identified an increasing need to provide additional technical and health education assistance in this region and this meeting was the perfect opportunity to bring the fish farmers and experts together.”

About Merck Animal Health
Today's Merck is a global healthcare leader working to help the world be well. Merck Animal Health, known as Merck Animal Health in the United States and Canada, is the global animal health business unit of Merck. Merck Animal Health offers veterinarians, farmers, pet owners and governments one of the widest range of veterinary pharmaceuticals, vaccines and health management solutions and services. Merck Animal Health is dedicated to preserving and improving the health, well-being and performance of animals. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. Merck Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit www.merck-animal-health.com.

Merck Forward-Looking Statement
This news release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such statements may include, but are not limited to, statements about the benefits of the merger between Merck and Schering-Plough, including future financial and operating results, the combined company’s plans, objectives, expectations and intentions and other statements that are not historical facts. Such statements are based upon the current beliefs and expectations of Merck’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements.

The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: the possibility that all of the expected synergies from the merger of Merck and Schering-Plough will not be realized, or will not be realized within the expected time period; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; Merck’s ability to accurately predict future market conditions; dependence on the effectiveness of Merck’s patents and other protections for innovative products; and the exposure to litigation and/or regulatory actions.

Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in Merck’s 2011 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).